HEC Pharm is the subsidiary of HEC Group, a research-based and internationally oriented company.
They have set themselves the goal of improving the health of people by providing them with high-quality medicines.
Excellence in research development and manufacturing of active ingredients and finished products in Asia, Europe and the United States and all the products meet the current regulatory requirements and international GMP standards. To provide their customers safe and user-friendly products and services is their ultimate goal in their business.
Their mission is shaped in the light of ethical standards and social responsibility, high quality and environmental awareness. For the implementation of their mission, they attach particular importance to:
Social Responsibility
In 2009, HEC made an agreement with the authorities of Ruyuan for the joint development of the Nanling National Park in Guangdong Province. The National Park covers much of the original forest, beautiful waterfalls and a wide variety of flora and fauna.
In 2010, under the direction of HEC and the Medical College of Shaoguan in northern Guangdong began to build a science campus with the goal to cultivate medical and pharmaceutical talents, doctors and train technicians.
The teaching and research institutions living quarters for teachers and students were built as well as university-related infrastructures.
HEC was authorized by Roche for the patent licensing agreement of Oseltamivir in China. In the year of 2009 ("swine flu" and "new flu") during the H1N1 crisis, HEC supplied 99% of the national demand of Ostamivir, therefore HEC was award by the "National Development & Reform Committee" for its great contribution to combat H1N1.